A new high-frequency magnetic stimulator is now in operation at Uralkali-Med, the dedicated medical subsidiary of Uralkali (the Company). The cutting-edge equipment was acquired as part of the Company’s social investment programme.
The advanced, Russian-made device is used for transcranial and peripheral magnetic stimulation across a range of medical fields to support rehabilitation and treatment for various conditions. The technique involves the use of short, high-frequency magnetic pulses with a strong magnetic field. The procedure is non-invasive and painless, making it an effective and safe tool in neurology, psychiatry, and paediatrics.
Treatment using the magnetic stimulator is available on prescription. For Uralkali’s employees, diagnostics and treatment are accessible through the corporate voluntary health insurance programme.
Irina Konstantinova, Uralkali Deputy CEO — HR and Communications Director:
We truly care about the of our employees and understand how vital access to high-quality healthcare is. That is why we continue to invest in new equipment. This high-frequency magnetic stimulator increases treatment efficiency and also speeds up the rehabilitation process. With our ongoing support, Uralkali-Med is continuously enhancing its facilities and expanding the range of medical services available for the benefit of our employees.
Uralkali PJSC (a part of Uralchem Group) is one of the world’s largest producers and exporters of potash. The Company’s assets consist of 5 mines and 7 ore treatment plants in the towns of Berezniki and Solikamsk (Perm Region, Russia).




